
Bumetanide
Composition
For injection- each mL contains 0.25 mg bumetanide, sodium chloride, ammonium acetate as buffer benzyl alcohol as preservative. For tablet- each tablet contain bumetanide USP 1 mg with other excipients accordingly.
Indications
It is indicated in patients to treat fluid retention caused due to congestive heart failure, liver disease, or kidney disorder.
Side effects
Mild to moderate side effect has been observed such as hypotension, encephalopathy, joint pain, seizures, encephalopathy
Precautions
This drug is to be cautiously used in patients with prostatic hypertrophy, liver and kidney disease pregnancy, and lactation.
Contraindications
This drug is contraindicated in patients with anuria, and hepatic coma.
Dosage and administration
Oral- In adult usual dose consists of a tablet 1 mg to be given orally with or without food. Parenteral- 0.5 – 1 mg administrated via IM
Countries
We have also established roots and begun this new venture in other countries as well such as Egypt, Argentina, and Hong Kong.
Available Forms
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai